Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences

NeuroReport

Volumn 15, Issue 13, 2004, Pages 2139-2143

  Le Foll, Bernard ^a   Goldberg, Steven R ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

CB1 receptors; Discrimination; Rats; Reward; Smoking

Indexed keywords

AMFEBUTAMONE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; NICOTINE; RIMONABANT; NICOTINIC AGENT; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG EFFECT; ENVIRONMENTAL FACTOR; MALE; NICOTINE REPLACEMENT THERAPY; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; ANIMAL; ANIMAL BEHAVIOR; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG INTERACTION; INSTRUMENTAL CONDITIONING; REINFORCEMENT; SPRAGUE DAWLEY RAT;

ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; NICOTINE; NICOTINIC AGONISTS; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; REINFORCEMENT (PSYCHOLOGY);

EID: 4644242739     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200409150-00028     Document Type: Article

References (24)

1. Ito R, Dalley JW, Howes SR, Robbins TW and Everitt BJ. Dissociation in conditioned dopamine release in the nucleus accumbens core and shell in response to cocaine cues and during cocaine-seeking behavior in rats. J Neurosci 2000; 20:7489-7495.
2. Goldberg SR and Gardner ML. Second-order schedules: extended sequences of behavior controlled by brief environmental stimuli associated with drug self-administration. NIDA Res Monogr 1981; 37:241-270.
3. Caggiula AR, Donny EC, White AR, Chaudhri N, Booth S, Gharib MA et al. Cue dependency of nicotine self-administration and smoking. Pharmacol Biochem Behav 2001; 70:515-530.
4. De Vries TJ, Shaham Y, Homberg JR, Crombag H, Schuurman K, Dieben J et al. A cannabinoid mechanism in relapse to cocaine seeking. Nature Med 2001; 7:1151-1154.
5. Tanda G, Munzar P and Goldberg SR. Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nature Neurosci 2000; 3:1073-1074.
6. Cohen C, Perrault G, Voltz C, Steinberg R and Soubrie P. SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav Pharmacol 2002; 13:451-163.
7. Goldberg SR, Spealman RD and Goldberg DM. Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science 1981; 214:573-575.
8. Gasior M, Shoaib M, Yasar S, Jaszyna M and Goldberg SR. Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine. J Pharmacol Exp Ther 1999; 288:1053-1073.
9. Young R and Glennon RA. Nicotine and bupropion share a similar discriminative stimulus effect. Eur J Pharmacol 2002; 443:113-118.
10. Wiley JL, Lavecchia KL, Martin BR and Damaj MI. Nicotine-like discriminative stimulus effects of bupropion in rats. Exp Clin Psychopharmacol 2002; 10:129-135.
11. Rodgers RJ, Haller J, Halasz J and Mikics E. 'One-trial sensitization' to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze. Eur J Neurosci 2003; 17:1279-1286.
12. Koob GF. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 1992; 13:177-184.
13. DeVries TJ, Shaham Y, Homberg JR, Crombag H, Schuurman K, Dieben J et al. A cannabinoid mechanism in relapse to cocaine seeking. Nature Med 2001; 7:1151-1154.
14. Chaperon F, Soubrie P, Puech AJ and Thiebot MH. Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats. Psychopharmacology (Berl) 1998; 135:324-332.
15. Fattore L, Martellotta MC, Cossu G, Mascia MS and Fratta W. CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats. Behav Brain Res 1999; 104:141-146.
16. 3 receptor agonist. Nature 1999; 400:371-375.
17. DiCiano P, Underwood RJ, Hagan JJ and Everitt BJ. Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A. Neuropsychopharmacology 2003; 28:329-338.
18. Le Foll B, Diaz J and Sokoloff P. Increased dopamine D3 receptor expression accompanying behavioural sensitization to nicotine in rats. Synapse 2003; 47:176-183.
19. Le Foll B, Francès H, Diaz J, Schwartz J-C and Sokoloff P. Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice. Eur J Neurosci 2002; 15:2016-2026.
20. Le Foll B, Schwartz J-C and Sokoloff P. Disruption of nicotine conditioning by dopamine D3 receptor ligands. Mol Psychiatry 2003; 8:225-230.
21. Vorel SR, Ashby CRJ, Paul M, Liu X, Hayes R, Hagan JJ et al. Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci 2002; 22:9595-9603.
22. Duarte C, Alonso R, Bichet N, Cohen C, Soubrie P and Thiebot MH. Blockade by the cannabinoid CB1 receptor antagonist, Rimonabant (SR141716), of the potentiation by Quinelorane of food-primed reinstatement of food-seeking behavior. Neuropsychopharmacology 2003; 29:911-920.
23. Mailleux P and Vanderhaeghen JJ. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 1992; 48:655-668.
24. Diaz J, Pilon C, Le Foll B, Gros C, Triller A, Schwartz JC and Sokoloff P. Dopamine D3 receptors expressed by all mesencephalic dopamine neurons. J Neurosci 2000; 20:8677-8684.